RAMIPRIL HOE498
RAMIP_L_03123
Approved small_molecule completed
Quick answer
RAMIPRIL HOE498 for Coronary Artery Disease is a Approved program (small_molecule) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pasteur
- Indication
- Coronary Artery Disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed